Luxembourg - Antihypertensive Medicine Use
Since 2014, Luxembourg Antihypertensive Medicine Use rose 1.2% year on year. In 2019, the country was number 16 among other countries in Antihypertensive Medicine Use at 5.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Luxembourg is overtaken by Greece, which was number 15 with 6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Estonia at 3.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Hungary topped the ranking with 34.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, +4.2% versus 2018. Lithuania, Slovakia and Slovenia respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +10.3% per year, while Slovakia recorded the worst performance at -9.8% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 5.30 |
| 2018 | 5.40 |
| 2017 | 5.30 |
| 2016 | 5.20 |
| 2015 | 5.10 |
How does Luxembourg rank in Antihypertensive Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Hungary
|
35 | 2019 | +4.2 % | +4.2 % | View data | |
| 2 |
#2
Lithuania
|
24 | 2019 | +4.7 % | -3.6 % | View data | |
| 15 |
#15
Greece
|
6 | 2019 | +1.7 % | +3.3 % | View data | |
| 16 |
#16
Luxembourg
|
5 | 2019 | -1.9 % | +1.2 % | View data | |
| 17 |
#17
Estonia
|
4 | 2019 | -2.6 % | -0.5 % | View data | |